Profound Medical Corp. (PROF)
USD 5.37
(-2.81%)
USD 5.37
(-2.81%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -27.12 Million USD | -9.81% |
| 2022 | -26.6 Million USD | 10.34% |
| 2021 | -28.64 Million USD | -70.82% |
| 2020 | -19.49 Million USD | -25.79% |
| 2019 | -12.52 Million CAD | 0.15% |
| 2018 | -13.24 Million CAD | -0.12% |
| 2017 | -13.22 Million CAD | -16.21% |
| 2016 | -15.49 Million CAD | -21.27% |
| 2015 | -11.14 Million CAD | -51.85% |
| 2014 | -4.25 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -7.54 Million USD | 1.45% |
| 2024 Q1 | -7.14 Million USD | 1.75% |
| 2023 Q1 | -6.21 Million USD | -12.7% |
| 2023 FY | - USD | -9.81% |
| 2023 Q4 | -8.71 Million USD | -38.97% |
| 2023 Q3 | -6.27 Million USD | -1.85% |
| 2023 Q2 | -6.15 Million USD | 0.96% |
| 2022 Q1 | -6.73 Million USD | 29.78% |
| 2022 Q3 | -7.61 Million USD | -8.18% |
| 2022 Q4 | -5.51 Million USD | 27.53% |
| 2022 Q2 | -7.03 Million USD | -4.5% |
| 2022 FY | - USD | 10.34% |
| 2021 FY | - USD | -70.82% |
| 2021 Q1 | -6.09 Million USD | -46.43% |
| 2021 Q3 | -7.09 Million USD | -20.98% |
| 2021 Q4 | -9.59 Million USD | -35.12% |
| 2021 Q2 | -5.86 Million USD | 3.8% |
| 2020 Q1 | -4.23 Million CAD | -12.08% |
| 2020 Q3 | -4.48 Million CAD | -31.77% |
| 2020 Q4 | -4.16 Million USD | 7.12% |
| 2020 FY | - USD | -25.79% |
| 2020 Q2 | -3.4 Million CAD | 19.56% |
| 2019 Q1 | -1.54 Million CAD | 38.95% |
| 2019 Q4 | -3.77 Million CAD | 8.78% |
| 2019 Q3 | -4.13 Million CAD | -9.38% |
| 2019 Q2 | -3.78 Million CAD | -144.65% |
| 2019 FY | - CAD | 0.15% |
| 2018 Q3 | -3.55 Million CAD | 7.92% |
| 2018 Q1 | -3.22 Million CAD | -8.42% |
| 2018 FY | - CAD | -0.12% |
| 2018 Q4 | -2.53 Million CAD | 28.76% |
| 2018 Q2 | -3.86 Million CAD | -19.88% |
| 2017 Q3 | -3.63 Million CAD | -6.27% |
| 2017 FY | - CAD | -16.21% |
| 2017 Q4 | -2.97 Million CAD | 18.27% |
| 2017 Q2 | -3.41 Million CAD | -21.38% |
| 2017 Q1 | -2.81 Million CAD | 15.74% |
| 2016 Q1 | -2.71 Million CAD | -79.11% |
| 2016 Q3 | -2.81 Million CAD | -8.91% |
| 2016 Q4 | -3.34 Million CAD | -18.85% |
| 2016 FY | - CAD | -21.27% |
| 2016 Q2 | -2.58 Million CAD | 4.9% |
| 2015 Q2 | -3.88 Million CAD | -19696.5% |
| 2015 Q1 | 19.84 Thousand CAD | -85.19% |
| 2015 Q4 | -1.51 Million CAD | 23.43% |
| 2015 FY | - CAD | -51.85% |
| 2015 Q3 | -1.98 Million CAD | 49.06% |
| 2014 Q1 | -21.17 Thousand CAD | 0.0% |
| 2014 Q4 | 134 Thousand CAD | 154.38% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | -246.41 Thousand CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -101.108% |
| Cerus Corporation | -26.53 Million USD | -2.214% |
| OrthoPediatrics Corp. | -8.38 Million USD | -223.63% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -158.454% |
| Talis Biomedical Corporation | -66.04 Million USD | 58.932% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -62.659% |
| Inogen, Inc. | -45.67 Million USD | 40.622% |
| Spectral AI, Inc. | -12.26 Million USD | -121.199% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 43.129% |
| CVRx, Inc. | -38.73 Million USD | 29.97% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -668.805% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -124.031% |
| Orthofix Medical Inc. | -86.98 Million USD | 68.818% |
| Venus Concept Inc. | -26.11 Million USD | -3.87% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 45.503% |
| Bioventus Inc. | -23.07 Million USD | -17.57% |
| BrainsWay Ltd. | -2.31 Million USD | -1073.667% |
| Envoy Medical, Inc. | -18.23 Million USD | -48.719% |
| electroCore, Inc. | -17.76 Million USD | -52.722% |
| IceCure Medical Ltd | -15.25 Million USD | -77.824% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 45.482% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -60.916% |
| MaxCyte, Inc. | -44.12 Million USD | 38.535% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -130.72% |
| Nexalin Technology, Inc. | -5.69 Million USD | -376.515% |
| PAVmed Inc | -75.74 Million USD | 64.19% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 49.545% |
| RxSight, Inc. | -41.03 Million USD | 33.905% |
| Sight Sciences, Inc. | -49.41 Million USD | 45.111% |
| SI-BONE, Inc. | -34.44 Million USD | 21.258% |
| TELA Bio, Inc. | -40.63 Million USD | 33.248% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 53.474% |
| Treace Medical Concepts, Inc. | -39 Million USD | 30.467% |
| LivaNova PLC | 39.01 Million USD | 169.519% |
| 908 Devices Inc. | -34.02 Million USD | 20.284% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 75.474% |
| Nemaura Medical Inc. | -7.28 Million USD | -272.214% |
| NeuroPace, Inc. | -22.83 Million USD | -18.785% |
| LENSAR, Inc. | -8.71 Million USD | -211.263% |
| Apyx Medical Corporation | -18.11 Million USD | -49.754% |
| Cutera, Inc. | -136.56 Million USD | 80.138% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -702.469% |
| BioSig Technologies, Inc. | -28.15 Million USD | 3.65% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1178.039% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -29.227% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 107.071% |
| Axonics, Inc. | 7.77 Million USD | 448.855% |
| Outset Medical, Inc. | -153.78 Million USD | 82.363% |
| IRIDEX Corporation | -7.44 Million USD | -264.171% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 72.35% |
| IRadimed Corporation | 20.8 Million USD | 230.397% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -236.436% |
| INVO Bioscience, Inc. | -6.88 Million USD | -294.235% |
| Telesis Bio, Inc. | -40.49 Million USD | 33.017% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 173.952% |
| Varex Imaging Corporation | 67.2 Million USD | 140.362% |
| Quipt Home Medical Corp. | 44.07 Million USD | 161.545% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -149.526% |
| Pulmonx Corporation | -55.09 Million USD | 50.767% |
| Dynatronics Corporation | -976 Thousand USD | -2679.02% |
| Modular Medical, Inc. | -17.1 Million USD | -58.589% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -87.252% |
| Semler Scientific, Inc. | 23.58 Million USD | 214.983% |
| InMode Ltd. | 196.28 Million USD | 113.819% |
| Bruker Corporation | 599 Million USD | 104.528% |
| Cytosorbents Corporation | -28.81 Million USD | 5.857% |
| DexCom, Inc. | 916.7 Million USD | 102.959% |
| Align Technology, Inc. | 799.03 Million USD | 103.395% |
| Viveve Medical, Inc. | -20.61 Million USD | -31.559% |
| ZimVie Inc. | 91.07 Million USD | 129.782% |
| Movano Inc. | -29.12 Million USD | 6.872% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -515.324% |
| Nexalin Technology, Inc. | -5.69 Million USD | -376.515% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -668.805% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 86.066% |
| Insulet Corporation | 323.6 Million USD | 108.382% |
| enVVeno Medical Corporation | -25.01 Million USD | -8.416% |
| Surmodics, Inc. | 1.18 Million USD | 2383.119% |
| iCAD, Inc. | -6.56 Million USD | -313.152% |
| Nuwellis, Inc. | -16.35 Million USD | -65.832% |
| Biotricity, Inc. | -8.82 Million USD | -207.234% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 71.998% |
| Aethlon Medical, Inc. | -11.84 Million USD | -128.907% |
| InspireMD, Inc. | -20.91 Million USD | -29.709% |
| PAVmed Inc. | -75.74 Million USD | 64.19% |
| BIOLASE, Inc. | -15.13 Million USD | -79.163% |
| Beyond Air, Inc. | -59.03 Million USD | 54.052% |
| FONAR Corporation | 28.25 Million USD | 196.007% |
| AxoGen, Inc. | -13.32 Million USD | -103.507% |
| Vivani Medical, Inc. | -26.6 Million USD | -1.937% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 210.523% |
| Inari Medical, Inc. | 7.11 Million USD | 481.322% |
| UFP Technologies, Inc. | 72.74 Million USD | 137.287% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -701.098% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -340.602% |
| Tenon Medical, Inc. | -15.52 Million USD | -74.674% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -77.672% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 34.604% |
| AdaptHealth Corp. | -171.09 Million USD | 84.147% |
| Sintx Technologies, Inc. | -6.6 Million USD | -310.961% |
| NanoVibronix, Inc. | -3.43 Million USD | -689.62% |
| Quanterix Corporation | -38.08 Million USD | 28.787% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -149.526% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 90511.513% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 90.218% |
| TransMedics Group, Inc. | -7.6 Million USD | -256.747% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -24.62% |
| NeuroMetrix, Inc. | -7.09 Million USD | -282.246% |
| Hyperfine, Inc. | -47.06 Million USD | 42.365% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 53.482% |
| Biomerica, Inc. | -5.99 Million USD | -352.586% |
| Bone Biologics Corporation | 479.57 Thousand USD | 5755.763% |
| AVITA Medical, Inc. | -39.56 Million USD | 31.451% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -195.69% |
| Silk Road Medical, Inc | -45.08 Million USD | 39.833% |